B cell-specific loss of lyn kinase leads to autoimmunity

Journal of Immunology

Volumn 192, Issue 3, 2014, Pages 919-928

  Lamagna, Chrystelle ^a   Hu, Yongmei ^a   DeFranco, Anthony L ^a   Lowell, Clifford A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE LYN; RIBONUCLEOPROTEIN ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW CELL; CALCIUM CELL LEVEL; CELL EXPANSION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; HOMEOSTASIS; IMMUNE COMPLEX NEPHRITIS; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; AUTOIMMUNITY; B-LYMPHOCYTES; CALCIUM SIGNALING; CELL COUNT; DISEASE MODELS, ANIMAL; GERMINAL CENTER; HOMEOSTASIS; IMMUNE COMPLEX DISEASES; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KIDNEY; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; LYMPHOPOIESIS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID DIFFERENTIATION FACTOR 88; MYELOPROLIFERATIVE DISORDERS; ORGAN SPECIFICITY; PLASMA CELLS; SPLEEN; SRC-FAMILY KINASES; T-LYMPHOCYTE SUBSETS;

EID: 84893392428     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301979     Document Type: Article

References (52)

1. Lowell, C. A. 2011. Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk. Cold Spring Harb. Perspect. Biol. 3: a002352.
2. Scapini, P., S. Pereira, H. Zhang, and C. A. Lowell. 2009. Multiple roles of Lyn kinase in myeloid cell signaling and function. Immunol. Rev. 228: 23-40.
3. Saijo, K., C. Schmedt, I. H. Su, H. Karasuyama, C. A. Lowell, M. Reth, T. Adachi, A. Patke, A. Santana, and A. Tarakhovsky. 2003. Essential role of Src-family protein tyrosine kinases in NF-kB activation during B cell development. Nat. Immunol. 4: 274-279.
4. Ohashi, P. S., and A. L. DeFranco. 2002. Making and breaking tolerance. Curr. Opin. Immunol. 14: 744-759.
5. DeFranco, A. L., V. W. Chan, and C. A. Lowell. 1998. Positive and negative roles of the tyrosine kinase Lyn in B cell function. Semin. Immunol. 10: 299-307.
6. Gross, A. J., I. Proekt, and A. L. DeFranco. 2011. Elevated BCR signaling and decreased survival of Lyn-deficient transitional and follicular B cells. Eur. J. Immunol. 41: 3645-3655.
7. Liossis, S. N., E. E. Solomou, M. A. Dimopoulos, P. Panayiotidis, M. M. Mavrikakis, and P. P. Sfikakis. 2001. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J. Investig. Med. 49: 157-165.
8. Harley, J. B., M. E. Alarcón-Riquelme, L. A. Criswell, C. O. Jacob, R. P. Kimberly, K. L. Moser, B. P. Tsao, T. J. Vyse, C. D. Langefeld, S. K. Nath, et al; International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN). 2008. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40: 204-210.
9. Gutierrez, T., K. E. Halcomb, A. J. Coughran, Q. Z. Li, and A. B. Satterthwaite. 2010. Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn-deficient mice. Eur. J. Immunol. 40: 1897-1905.
10. Chan, V. W., F. Meng, P. Soriano, A. L. DeFranco, and C. A. Lowell. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7: 69-81.
11. Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker, and A. R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83: 301-311.
12. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3: 549-560.
13. Allman, D., R. C. Lindsley, W. DeMuth, K. Rudd, S. A. Shinton, and R. R. Hardy. 2001. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167: 6834-6840.
14. Cornall, R. J., J. G. Cyster, M. L. Hibbs, A. R. Dunn, K. L. Otipoby, E. A. Clark, and C. C. Goodnow. 1998. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8: 497-508.
15. Meade, J., C. Fernandez, and M. Turner. 2002. The tyrosine kinase Lyn is required for B cell development beyond the T1 stage in the spleen: rescue by overexpression of Bcl-2. Eur. J. Immunol. 32: 1029-1034.
16. Gross, A. J., J. R. Lyandres, A. K. Panigrahi, E. T. Prak, and A. L. DeFranco. 2009. Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance. J. Immunol. 182: 5382-5392.
17. Scapini, P., Y. Hu, C. L. Chu, T. S. Migone, A. L. Defranco, M. A. Cassatella, and C. A. Lowell. 2010. Myeloid cells, BAFF, and IFN-g establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J. Exp. Med. 207: 1757-1773.
18. Lamagna, C., P. Scapini, J. A. van Ziffle, A. L. DeFranco, and C. A. Lowell. 2013. Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation. Proc. Natl. Acad. Sci. USA 110: E3311-E3320.
19. Hobeika, E., S. Thiemann, B. Storch, H. Jumaa, P. J. Nielsen, R. Pelanda, and M. Reth. 2006. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl. Acad. Sci. USA 103: 13789-13794.
20. Hou, B., B. Reizis, and A. L. DeFranco. 2008. Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms. Immunity 29: 272-282.
21. Zikherman, J., R. Parameswaran, and A. Weiss. 2012. Endogenous antigen tunes the responsiveness of naive B cells but not T cells. Nature 489: 160-164.
22. Shahaf, G., A. J. Gross, M. Sternberg-Simon, D. Kaplan, A. L. DeFranco, and R. Mehr. 2012. Lyn deficiency affects B-cell maturation as well as survival. Eur. J. Immunol. 42: 511-521.
23. Chan, V. W., C. A. Lowell, and A. L. DeFranco. 1998. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr. Biol. 8: 545-553.
24. Tsantikos, E., S. A. Oracki, C. Quilici, G. P. Anderson, D. M. Tarlinton, and M. L. Hibbs. 2010. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6. J. Immunol. 184: 1348-1360.
25. Tsantikos, E., C. Quilici, K. W. Harder, B. Wang, H. J. Zhu, G. P. Anderson, D. M. Tarlinton, and M. L. Hibbs. 2009. Perturbation of the CD4 T cell compartment and expansion of regulatory T cells in autoimmune-prone Lyn-deficient mice. J. Immunol. 183: 2484-2494.
26. Scapini, P., C. Lamagna, Y. Hu, K. Lee, Q. Tang, A. L. DeFranco, and C. A. Lowell. 2011. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice. Proc. Natl. Acad. Sci. USA 108: E823-E832.
27. Hou, B., P. Saudan, G. Ott, M. L. Wheeler, M. Ji, L. Kuzmich, L. M. Lee, R. L. Coffman, M. F. Bachmann, and A. L. DeFranco. 2011. Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity 34: 375-384.
28. Shlomchik, M. J. 2009. Activating systemic autoimmunity: B's, T's, and Tolls. Curr. Opin. Immunol. 21: 626-633.
29. Ganguly, D., S. Haak, V. Sisirak, and B. Reizis. 2013. The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 13: 566-577.
30. Harder, K. W., L. M. Parsons, J. Armes, N. Evans, N. Kountouri, R. Clark, C. Quilici, D. Grail, G. S. Hodgson, A. R. Dunn, and M. L. Hibbs. 2001. Gainand loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage. Immunity 15: 603-615.
31. Liu, K., Q. Z. Li, Y. Yu, C. Liang, S. Subramanian, Z. Zeng, H.W. Wang, C. Xie, X. J. Zhou, C. Mohan, and E. K.Wakeland. 2007. Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis. Genes Immun. 8: 634-645.
32. Green, N. M., and A. Marshak-Rothstein. 2011. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin. Immunol. 23: 106-112.
33. Ehlers, M., H. Fukuyama, T. L. McGaha, A. Aderem, and J. V. Ravetch. 2006. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 203: 553-561.
34. Nickerson, K. M., S. R. Christensen, J. Shupe, M. Kashgarian, D. Kim, K. Elkon, and M. J. Shlomchik. 2010. TLR9 regulates TLR7-And MyD88-dependent autoantibody production and disease in a murine model of lupus. J. Immunol. 184: 1840-1848.
35. Teichmann, L. L., D. Schenten, R. Medzhitov, M. Kashgarian, and M. J. Shlomchik. 2013. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity 38: 528-540.
36. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
37. Amezcua Vesely, M. C., M. Schwartz, D. A. Bermejo, C. L. Montes, K. M. Cautivo, A. M. Kalergis, D. J. Rawlings, E. V. Acosta-Rodríguez, and A. Gruppi. 2012. FcgRIIb and BAFF differentially regulate peritoneal B1 cell survival. J. Immunol. 188: 4792-4800.
38. Thien, M., T. G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20: 785-798.
39. Fletcher, C. A., J. R. Groom, B. Woehl, H. Leung, C. Mackay, and F. Mackay. 2011. Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice. J. Autoimmun. 36: 125-134.
40. Kato, J., N. Motoyama, I. Taniuchi, H. Takeshita, M. Toyoda, K. Masuda, and T. Watanabe. 1998. Affinity maturation in Lyn kinase-deficient mice with defective germinal center formation. J. Immunol. 160: 4788-4795.
41. Mirnics, Z. K., E. Caudell, Y. Gao, K. Kuwahara, N. Sakaguchi, T. Kurosaki, J. Burnside, K. Mirnics, and S. J. Corey. 2004. Microarray analysis of Lyndeficient B cells reveals germinal center-Associated nuclear protein and other genes associated with the lymphoid germinal center. J. Immunol. 172: 4133-4141.
42. Sweet, R. A., J. L. Cullen, and M. J. Shlomchik. 2013. Rheumatoid factor B cell memory leads to rapid, switched antibody-forming cell responses. J. Immunol. 190: 1974-1981.
43. Silver, K. L., T. L. Crockford, T. Bouriez-Jones, S. Milling, T. Lambe, and R. J. Cornall. 2007. MyD88-dependent autoimmune disease in Lyn-deficient mice. Eur. J. Immunol. 37: 2734-2743.
44. Pao, L. I., K. P. Lam, J. M. Henderson, J. L. Kutok, M. Alimzhanov, L. Nitschke, M. L. Thomas, B. G. Neel, and K. Rajewsky. 2007. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27: 35-48.
45. O'Keefe, T. L., G. T. Williams, F. D. Batista, and M. S. Neuberger. 1999. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189: 1307-1313.
46. Abram, C. L., G. L. Roberge, L. I. Pao, B. G. Neel, and C. A. Lowell. 2013. Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice. Immunity 38: 489-501.
47. Tavares, R. M., E. E. Turer, C. L. Liu, R. Advincula, P. Scapini, L. Rhee, J. Barrera, C. A. Lowell, P. J. Utz, B. A. Malynn, and A. Ma. 2010. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity 33: 181-191.
48. Ma, A., and B. A. Malynn. 2012. A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat. Rev. Immunol. 12: 774-785.
49. Hammer, G. E., E. E. Turer, K. E. Taylor, C. J. Fang, R. Advincula, S. Oshima, J. Barrera, E. J. Huang, B. Hou, B. A. Malynn, et al. 2011. Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat. Immunol. 12: 1184-1193.
50. Kool, M., G. van Loo, W. Waelput, S. De Prijck, F. Muskens, M. Sze, J. van Praet, F. Branco-Madeira, S. Janssens, B. Reizis, et al. 2011. The ubiquitinediting protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity 35: 82-96.
51. Rullo, O. J., and B. P. Tsao. 2013. Recent insights into the genetic basis of systemic lupus erythematosus. Ann. Rheum. Dis. 72(Suppl. 2): ii56-ii61.
52. Hua, Z., A. Gross, C. Lamagna, N. M. Ramos-Hernandez, P. Scapini, M. Ji, H. Shao, C. A. Lowell, and A. L. DeFranco. 2014. Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice. J. Immunol. 192: 875-885.